Affinage

Showing PPP1R18PHOSTENSIN is a alias.

PPP1R18

Phostensin · UniProt Q6NYC8

Length
613 aa
Mass
67.9 kDa
Annotated
2026-06-10
12 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PPP1R18 (phostensin) is a protein phosphatase 1 (PP1) regulatory subunit and actin-binding protein that couples PP1 activity to the actin cytoskeleton and to actin-dependent cellular processes (PMID:17374523). It recruits PP1 to F-actin at the cell periphery (PMID:17374523) and acts directly on actin dynamics by capping filament pointed ends, slowing both elongation and depolymerization (PMID:19622346); this capping requires a C-terminal actin-binding motif (residues 129–155) together with an N-terminal element (residues 35–51) that sterically restricts side-binding and confers pointed-end specificity (PMID:23443105). The gene encodes both a short (~26 kDa) and an upstream-initiated long (~110 kDa) isoform, both of which retain PP1 and actin-filament binding (PMID:24434620). Through these activities PPP1R18 controls actin-dependent functions in distinct cell types: in osteoclasts it localizes to the actin ring and suppresses terminal differentiation, actin ring formation, and bone resorption in a PP1-binding-dependent manner (PMID:29158294), and in lymphocytes it forms part of the Rap1/MRL-integrin-talin (MIT) complex, where it dephosphorylates Rap1 to preserve Rap1 activity and membrane localization, enabling integrin activation and lymphocyte trafficking (PMID:35766979). PPP1R18 additionally binds the endocytic regulators EHD1 and EHD4 through a non-canonical ILV-RL motif (residues 51–80) to attenuate transferrin endocytic recycling (PMID:32800345, PMID:39776131).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2007 High

    Established that phostensin physically links PP1 to the actin cytoskeleton, defining it as an actin-targeting PP1 regulatory subunit.

    Evidence Yeast two-hybrid, reciprocal Co-IP, GST pull-down, and immunofluorescence in MDCK cells

    PMID:17374523

    Open questions at the time
    • Did not identify which PP1-dependent substrates are dephosphorylated at the cytoskeleton
    • Functional consequence of PP1 recruitment to F-actin not tested
  2. 2009 High

    Resolved how phostensin affects actin directly by showing it caps filament pointed ends and damps their kinetics, establishing a direct cytoskeletal-modulating activity independent of PP1.

    Evidence In vitro gelsolin-actin seed elongation/depolymerization assays and single-filament fluorescence binding

    PMID:19622346

    Open questions at the time
    • Capping demonstrated in vitro only
    • Cellular consequence of pointed-end capping not addressed
  3. 2012 High

    Mapped the structural basis of pointed-end specificity to a bipartite arrangement of an N-terminal positioning element and a C-terminal actin-binding motif.

    Evidence F-actin co-sedimentation, single-filament binding, and truncation/deletion analysis

    PMID:23443105

    Open questions at the time
    • No high-resolution structure of the actin-bound complex
    • Regulation of the N-terminal steric mechanism unknown
  4. 2014 Medium

    Showed that KIAA1949 produces a distinct long isoform (phostensin-β) from an upstream start site that retains PP1 and actin binding, indicating isoform-specific functional potential.

    Evidence 5'-RACE, immunoprecipitation/shotgun proteomics, SDS-PAGE, binding assays

    PMID:24434620

    Open questions at the time
    • Functional differences between α and β isoforms not defined
    • Tissue-specific isoform expression not characterized
  5. 2011 Medium

    Connected phostensin localization to immune cells, showing peripheral actin co-localization and expression restricted to mature thymic lymphocytes.

    Evidence Monoclonal antibody immunofluorescence and immunohistochemistry of lymphatic tissues

    PMID:21804078

    Open questions at the time
    • Correlative localization only, no functional perturbation
    • Link to lymphocyte maturation not mechanistically tested
  6. 2017 High

    Demonstrated a physiological cytoskeletal role in osteoclasts, where phostensin is an Src-binding protein that suppresses actin ring formation and bone resorption in a PP1-binding-dependent manner.

    Evidence Co-IP, overexpression/knockdown in osteoclasts, PP1-binding domain mutagenesis rescue, actin ring and bone resorption assays

    PMID:29158294

    Open questions at the time
    • Src-phostensin interaction consequence not resolved
    • PP1 substrate(s) in osteoclasts not identified
  7. 2020 Medium

    Identified an endocytic function by linking phostensin to the EHD1/EHD4 recycling machinery and showing it attenuates transferrin trafficking.

    Evidence Co-IP/shotgun proteomics, GST pull-down, immunofluorescence, transferrin trafficking assay

    PMID:32800345

    Open questions at the time
    • Binding interface not yet defined at this stage
    • Whether PP1 activity contributes to endocytic regulation untested
  8. 2022 High

    Defined a substrate-level mechanism in immunity: phostensin dephosphorylates Rap1 within the MIT complex to sustain integrin activation and lymphocyte trafficking.

    Evidence Tandem-affinity proteomics, CRISPR KO in Jurkat cells, Ppp1r18-/- mouse, integrin activation, adoptive-transfer colitis model

    PMID:35766979

    Open questions at the time
    • Direct enzymatic dephosphorylation of Rap1 by the PP1/phostensin complex not biochemically reconstituted
    • Relationship between actin-capping and Rap1 regulation unresolved
  9. 2025 High

    Pinpointed the EHD-binding determinant as a non-canonical ILV-RL motif and proved it is required for regulation of endocytic recycling.

    Evidence GST pull-down, far western blotting, site-directed mutagenesis, transferrin trafficking rescue in 293T cells

    PMID:39776131

    Open questions at the time
    • Structural basis of the non-NPF EHD interaction unknown
    • Physiological endocytic cargoes beyond transferrin not defined
  10. 2024 Medium

    Extended PPP1R18 into oncogenic signaling, showing it promotes ESCC progression via the calcineurin-ERK pathway rather than direct PPP1CA binding.

    Evidence Overexpression/knockdown in ESCC lines, xenograft, pathway Western blots, inhibitor experiments

    PMID:38715543

    Open questions at the time
    • Mechanistic link between phostensin and calcineurin not resolved
    • How a PP1-targeting protein acts independently of PPP1CA here is unclear

Open questions

Synthesis pass · forward-looking unresolved questions
  • How phostensin's distinct activities — pointed-end actin capping, PP1 recruitment, Rap1 dephosphorylation, and EHD-dependent recycling — are integrated and selectively engaged in different cell types remains unresolved.
  • No unified model coupling actin capping to PP1 substrate selection
  • Isoform-specific division of these functions undefined
  • No structure of phostensin in any of its functional complexes

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 3 GO:0098772 molecular function regulator activity 3 GO:0060090 molecular adaptor activity 2
Localization
GO:0005856 cytoskeleton 3 GO:0005886 plasma membrane 2 GO:0031410 cytoplasmic vesicle 1
Pathway
R-HSA-5653656 Vesicle-mediated transport 2 R-HSA-168256 Immune System 1
Complex memberships
PP1/phostensin complexRap1/MRL-integrin-talin (MIT) complex

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2007 Phostensin (PPP1R18/KIAA1949) associates with protein phosphatase 1 (PP1) and targets the PP1/phostensin complex to the F-actin cytoskeleton at the cell periphery in MDCK epithelial cells. Yeast two-hybrid assay, co-immunoprecipitation, GST pull-down assay, immunofluorescence microscopy Biochemical and biophysical research communications High 17374523
2009 Phostensin caps the pointed ends of actin filaments, decreasing both elongation and depolymerization rates at the pointed end; this was demonstrated using gelsolin-actin seed elongation assays and fluorescent single-filament binding assay. Actin dynamics assays (gelsolin-actin seeds), fluorescent single filament binding assay Biochemical and biophysical research communications High 19622346
2012 The actin-binding motif of phostensin resides in its C-terminal region (residues 129–155), while pointed-end capping additionally requires N-terminal residues 35–51; the N-terminal region sterically prevents the C-terminus from binding actin filament sides, enabling pointed-end specificity. Colocalization, F-actin co-sedimentation assay, single filament binding assay, truncation/deletion analysis International journal of molecular sciences High 23443105
2014 A high-molecular-weight isoform of phostensin, phostensin-β (613 aa, ~110 kDa), is encoded by KIAA1949 from an upstream start site; phostensin-β retains the ability to associate with PP1 and actin filaments and is distinct from (not a degradation product of) phostensin-α (165 aa, ~26 kDa). 5'-RACE, immunoprecipitation combined with shotgun proteomics, SDS-PAGE, functional binding assays International journal of molecular sciences Medium 24434620
2011 Phostensin is concentrated at the cell periphery and co-localizes with actin filaments in leukocytes; it is expressed in mature but not immature thymic lymphocytes, suggesting a role linked to lymphocyte maturation. Anti-phostensin monoclonal antibody (PT2) immunofluorescence, immunohistochemistry of lymphatic tissues The journal of histochemistry and cytochemistry Medium 21804078
2018 PPP1r18 is identified as an Src-binding protein; it localizes to the nucleus and actin ring in osteoclasts. Overexpression of PPP1r18 inhibits osteoclast terminal differentiation, actin ring formation, and bone resorption, while knockdown promotes these processes. A mutation of the PP1-binding domain of PPP1r18 rescues the inhibitory phenotype of overexpression, indicating that PP1 binding mediates PPP1r18's inhibitory effect on osteoclast function. Co-immunoprecipitation (Src binding), overexpression and knockdown in osteoclasts, PP1-binding domain mutagenesis, actin ring formation and bone resorption assays, immunofluorescence localization Molecular and cellular biology High 29158294
2020 Phostensin associates with EHD1 and EHD4 (Eps15 homology domain-containing proteins); the phostensin/EHD complex co-localizes at endocytic vesicles, and overexpression of phostensin-β attenuates endocytic trafficking of transferrin. Co-immunoprecipitation combined with shotgun proteomics, GST pull-down assay, immunofluorescence microscopy, transferrin endocytic trafficking assay Biochemical and biophysical research communications Medium 32800345
2022 Phostensin (Ptsn) is a component of the Rap1/MRL protein-integrin-talin (MIT) complex in lymphocytes; it mediates dephosphorylation of Rap1, thereby preserving Rap1 activity and membrane localization to stabilize the MIT complex, enabling integrin (αLβ2 and α4β7) activation and lymphocyte trafficking to peripheral lymphoid organs. Tandem affinity tag-based proteomics (MIT complex isolation), CRISPR/Cas9 PPP1R18 deletion in Jurkat T cells, Ppp1r18-/- mouse model, integrin activation assays, adoptive transfer colitis model The Journal of experimental medicine High 35766979
2025 Phostensin binds EHD1 and EHD4 via a novel consensus motif (64ILV(X)4(L/V)RL74S) in residues 51–80, not via the canonical NPF motif; alanine substitutions in this motif reduce binding in GST pull-down and far western blotting, and overexpression of a PPP1r18-β mutant with a defective EHD-binding motif fails to attenuate transferrin endocytic recycling, demonstrating that EHD1/EHD4 binding is required for PPP1r18's regulation of endocytic recycling. GST pull-down assay, far western blotting, site-directed mutagenesis of binding motif, transferrin endocytic trafficking assay in 293T cells Journal of biochemistry High 39776131
2024 PPP1r18 promotes ESCC tumor progression through activation of the calcineurin-mediated ERK pathway rather than through direct binding to PP1 catalytic subunit alpha (PPP1CA); PPP1r18 overexpression enhanced cell proliferation in vitro and in vivo. PPP1r18 overexpression and knockdown in ESCC cell lines, in vivo xenograft, Western blotting for pathway components, pathway inhibitor experiments Carcinogenesis Medium 38715543

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2007 Identification of phostensin, a PP1 F-actin cytoskeleton targeting subunit. Biochemical and biophysical research communications 35 17374523
2010 Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis. Journal of Cancer 29 20842223
2009 Phostensin caps to the pointed end of actin filaments and modulates actin dynamics. Biochemical and biophysical research communications 22 19622346
2018 The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts. Molecular and cellular biology 18 29158294
2012 Identification and characterization of the actin-binding motif of phostensin. International journal of molecular sciences 9 23443105
2011 Immunolocalization of phostensin in lymphatic cells and tissues. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 9 21804078
2014 Identification of the high molecular weight isoform of phostensin. International journal of molecular sciences 6 24434620
2022 Phostensin enables lymphocyte integrin activation and population of peripheral lymphoid organs. The Journal of experimental medicine 3 35766979
2020 Identification of phostensin in association with Eps 15 homology domain-containing protein 1 (EHD1) and EHD4. Biochemical and biophysical research communications 2 32800345
2024 PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway. Carcinogenesis 1 38715543
2026 PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma. Cancer cell international 0 42108458
2025 Identification of a novel Eps 15 homology domain-containing protein 1 (EHD1) and EHD4-binding motif in phostensin. Journal of biochemistry 0 39776131

Missed literature

Know a paper Affinage missed for PPP1R18? Flag it for the maintainers and the community.

No submissions yet.